The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Sickle cell anemia as an inflammatory disease
Open accessAbstract
The classical view of sickle cell anemia has always focused on the primary genetic defect — the abnormal sickle hemoglobin that polymerizes when deoxygenated. Polymerization within the red cell causes it to deform, to become rigid, to obstruct blood flow, and to produce acute and chronic tissue damage because of poor perfusion. A more holistic view sees the sickle red cell with its abnormal contents and membrane in a larger context — as it interacts with, damages, and stimulates the vascular endothelium and surrounding tissues and cells. This view allows examination of the hypothesis that the sticky, stiff, oxidizing sickle red cell is an irritant that provokes an inflammatory response as it obstructs flow. The tissues are not only under-perfused, but also exposed to inflammatory cytokines, growth factors, and the actions of the activated cells that respond to and produce them. The article by Kaul and Hebbel in this issue of the JCI (1) suggests that reperfusion injury plays a major role in sickle pathophysiology and provides new insights that contribute to this broader view of the disease process. Using a transgenic sickle mouse model and directly visualizing the microcirculation in a living open cremaster muscle preparation, the authors make three key observations that implicate reperfusion injury (1). First, after 3 hours of mild hypoxia followed by reoxygenation, the vascular bed of the sickle mouse (but not control) showed a distinct inflammatory response with increased leukocyte rolling, adhesion, and emigration. Second, the reoxygenation resulted in conversion in endothelial cells of the oxidant-sensitive probe dihydrorhodamine to the fluorescent compound rhodamine, suggesting local production of H2O2. Third, the abnormal rolling, adhesion, and migration of leukocytes were prevented by infusion with a monoclonal murine P-selectin antibody before reoxygenation. This theme of reactive oxygen species generation and P-selectin-sensitive leukocyte adhesion and migration is consonant with a variety of reperfusion injury models. The implication is that once oxygen is restored to ischemic tissues, oxygen radicals are formed, and inflammatory endothelial and tissue injury occurs. This is a particularly attractive model for sickle cell anemia — especially for the chronic subliminal organ damage that typically occurs in the spleen, lung, and kidney. In the vascular beds of these organs, young reticulocytes periodically attach to endothelial cells and, if conditions are right, cause a transient logjam of relatively rigid deoxygenating mature red cells in their wake (2). As the obstruction eventually clears, the reperfusion pathophysiology plays out, escalating the likelihood of additional rounds of reticulocyte adhesion to the inflamed endothelium that is becoming increasingly decorated with large unyielding leukocytes. These repetitive episodes of localized ischemia and reperfusion can set up a low-grade chronic inflammatory tissue-injuring state. The authors support the concept of chronic inflammation by pointing out the abnormally high base-line leukocyte count in the sickle mouse, an abnormality that is also found in humans with sickle cell disease (3). Even more impressive is the increasing number of epidemiological studies that implicate base-line leukocyte count as a major risk factor for severity in sickle cell anemia. Despite the fact that all individuals with sickle cell anemia have the identical globin gene mutation, there is a wide range of clinical severity. For example, the most common clinical manifestation of the disease, the pain crisis, varies tremendously among individuals, with rates ranging from 0 per year to more than 10 per year (4). It was no surprise to discover that some of the typical clinical complications of sickle cell anemia were less common among those individuals with higher levels of fetal hemoglobin (4–6). What has been surprising is the emerging evidence that the base-line leukocyte count is also a very important independent risk factor for disease severity. Patients with high base-line leukocyte counts are more likely to die at a younger age (5). Such patients are also more susceptible to the acute chest syndrome, an effect that is of similar magnitude to that of fetal hemoglobin over the range of fetal hemoglobin and leukocyte counts in the population (6). Base-line leukocyte counts are also risk factors for the development of silent brain infarcts (7). Most recently, the base-line leukocyte count was shown to be a strong predictor of which infants with sickle cell anemia will develop clinically severe disease (8). In the context of these epidemiological studies, it is impossible to determine whether the base-line leukocyte count simply reflects ongoing base-line chronic inflammation, or whether it indicates the propensity to develop an inflammatory response to a given stimulus. The observation that base-line leukocyte count has a heritability estimate of 0.62 in
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 1×
“Patients with high baseline leukocyte counts are more likely to die at a younger age (5).”
BackgroundSelf-citationPain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Self-citationCastro, O., Brambilla, D., Thorington, B., Reindorf, C., Scott, R., Gillette, P., Vera, J., & Levy, P. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 808
Prediction of Adverse Outcomes in Children with Sickle Cell Disease
Miller, S. T., Sleeper, L. A., Pegelow, C. H., Enos, L. E., Wang, W. C., Weiner, S. J., Wethers, D. L., Smith, J., & Kinney, T. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420203 · Cited by 508 · cited 1×
“line leukocyte count was shown to be a strong predictor of which infants with sickle cell anemia will develop clinically severe disease (8).”
BackgroundMortality in Sickle Cell Disease
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311515 · Cited by 459
Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
Kaul, D. K., & Hebbel, R. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9225 · Cited by 417
Silent cerebral infarcts in sickle cell anemia: a risk factor analysis
Kinney, T. R., Sleeper, L. A., Wang, W. C., Zimmerman, R. A., Pegelow, C. H., Ohene-Frempong, K., Wethers, D. L., Bello, J. A., Vichinsky, E. P., Moser, F. G., et al. (1999) · PEDIATRICS · doi:10.1542/peds.103.3.640 · Cited by 309
Self-citationGenetic influences on F cells and other hematologic variables: a twin heritability study
Garner, C., Tatu, T., Reittie, J. E., Littlewood, T., Darley, J., Cervino, S., Farrall, M., Kelly, P., Spector, T. D., & Thein, S. L. (2000) · Blood · doi:10.1182/blood.v95.1.342 · Cited by 274
Laboratory profile of sickle cell disease: a cross-sectional analysis
STEWARTWEST, M. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90073-v · Cited by 136 · cited 1×
“The authors support the concept of chronic inflammation by pointing out the abnormally high base-line leukocyte count in the sickle mouse, an abnormality that is also found in humans with sickle cell disease (3).”
BackgroundBlockade of Adhesion of Sickle Cells to Endothelium by Monoclonal Antibodies
Hebbel, R. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422512 · Cited by 81
Cited by
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Proia, R. L., & Hla, T. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76369 · Cited by 528
Pulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Sickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 445
Yazdanbakhsh, K., Ware, R. E., & Noizat-Pirenne, F. (2012) · Blood · doi:10.1182/blood-2011-11-327361 · Cited by 404
Cardiovascular Abnormalities in Sickle Cell Disease
Gladwin, M. T., & Sachdev, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.900 · Cited by 276
Metadata
- Authors
- Platt, O. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-08-01
- Volume
- 106
- Issue
- 3
- Pages
- 337-338
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2150182456
- Cited by
- 293
- References
- 10
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.